Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03441048 Background | May 2018 → May 2024 | acute myeloid leukemia | Medical College of Wisconsin | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03441048 ↗ |
| Modality | Protein / enzyme biologic | “G-CSF is a glycoprotein” NCT03441048 ↗ |